Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults.
Autor: | Murphy, M. G., Bach, M. A., Plotkin, D., Bolognese, J., Ng, J., Krupa, D., Cerchio, K., Gertz, B. J. |
---|---|
Zdroj: | Journal of Bone & Mineral Research; Jul1999, Vol. 14 Issue 7, p1182-1188, 7p |
Databáze: | Complementary Index |
Externí odkaz: |